Trials / Terminated
TerminatedNCT00664066
DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
A Non-Interventional, Post-Authorisation Study to Assess Adverse Events and Drug Utilisation Among Chronic Kidney Disease Patients Treated With DYNEPO
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a post-authorisation safety study to assess the incidence and severity of all pre-defined cardiovascular events in patients treated with DYNEPO, as well as to detect \& describe less common adverse drug reactions, and to summarise DYNEPO drug utilisation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DYNEPO (epoetin delta) | dose, dose frequency, route of administration (iv or sc) and duration will be determined by the investigator according to their normal prescribing habits, as this is an observational study |
Timeline
- Start date
- 2008-04-25
- Primary completion
- 2008-07-30
- Completion
- 2008-07-30
- First posted
- 2008-04-22
- Last updated
- 2021-06-25
- Results posted
- 2009-09-28
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00664066. Inclusion in this directory is not an endorsement.